Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-19-052261

Options or other derivatives

  • Director acquired 13,646 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ferrante Karen Jean Director 2019-10-01 Grant or award · Stock Option (Right to Buy) +13,646 $0.88 $12,000 13,646 D
Loading xslF345X03/doc4.xml…